Article info
Drug therapy
Short report
Efficacy and treatment costs of zoledronate versus pamidronate in paediatric osteoporosis
- Correspondence to Dr Wolfgang Högler, Department of Endocrinology and Diabetes, Birmingham Children’s Hospital, Steelhouse Lane, Birmingham B4 6NH, UK; wolfgang.hogler{at}bch.nhs.uk
Citation
Efficacy and treatment costs of zoledronate versus pamidronate in paediatric osteoporosis
Publication history
- Received April 20, 2017
- Revised September 4, 2017
- Accepted September 11, 2017
- First published October 7, 2017.
Online issue publication
December 13, 2017
Article Versions
- Previous version (7 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.